On Wednesday shares of ChannelAdvisor Corporation (NYSE:ECOM) closed at $11.15. Company’s sales growth for last 5 years was 18.90% and EPS growth for next 5 years is recorded as 20.00%. ChannelAdvisor Corporation (NYSE:ECOM) participated in Demandware’s 2015 XChange Conference, took place April 13-15 at the Aria Resort & Casino in Las Vegas. ChannelAdvisor was a Silver sponsor of this event and had experts available throughout the three-day conference to discuss ongoing trends in e-commerce, as well as the ChannelAdvisor platform.
Bristol-Myers Squibb Company (NYSE:BMY) in last trading activity decreased -0.94% to close at $63.43. Company weekly performance is -0.14% while its quarterly performance stands at 1.07%. Bristol-Myers Squibb Company (NYSE:BMY) is -7.81% away from its 52 week high. On April 8, Bristol-Myers Squibb Company (NYSE:BMY) announced that it has completed the previously announced planned acquisition of Flexus Biosciences Inc. The transaction includes full rights to F001287 Flexus’ lead preclinical small-molecule IDO1-inhibitor targeted for IND filing in the second half of 2015 and an IDO/TDO discovery program that includes its IDO-selective IDO/TDO dual and TDO-selective compound libraries.
On last trading day Hancock Holding Company (NASDAQ:HBHC) increased 3.19% to close at $31.07. Its volatility for the week is 2.87% while volatility for the month is 2.51%. HBHC’s sales growth for past 5 years was 16.40% and its EPS growth for past 5 years was -1.50%. Hancock Holding Company (NASDAQ:HBHC) monthly performance is 3.98%. On Tuesday Nasdaq and EverFi honored Hancock Holding Company (NASDAQ:HBHC) with the Innovation in Financial Education Award at a ceremony hosted at Nasdaq’s Marketsite headquarters in New York City. The award recognizes the company’s significant efforts to improve the financial knowledge and capabilities of young Americans. Only 25 financial institutions received this distinction.
On Wednesday shares of Merck & Co. Inc. (NYSE:MRK) closed at $58.45. Company’s sales growth for last 5 years was 9.00% and EPS growth for next 5 years is recorded as 4.55%. Merck & Co Inc. (NYSE:MRK) and NewLink Genetics have confirmed that the third, late-stage, clinical trial of their Ebola vaccine candidate rVSV-ZEBOV-GP (V920) has begun in Sierra Leone. The Phase II/III safety and effectiveness STRIVE trial will involve 6,000 health and other frontline workers, and is being led by the Sierra Leone College of Medicine and Allied Health Sciences, Sierra Leone Ministry of Health and Sanitation, and the US Centres for Disease Control and Prevention.
On last trading day Simpson Manufacturing Co., Inc. (NYSE:SSD) increased 0.58% to close at $36.67. Its volatility for the week is 1.85% while volatility for the month is 1.84%. SSD’s sales growth for past 5 years was 7.40% and its EPS growth for past 5 years was 34.80%. Simpson Manufacturing Co., Inc. (NYSE:SSD) monthly performance is -0.65%. DA Davidson cut shares of Simpson Manufacturing Co (NYSE:SSD) from a buy rating to a neutral rating in a research report sent to investors on Monday morning,TheFlyOnTheWall.com reports. The firm currently has $40.00 price target on the stock. The analysts noted that the move was a valuation call.